This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Heightened Focus On Patient Safety To Spur Demand For Patient Prepping Products, Finds Frost & Sullivan

LONDON, Jan. 16, 2013 /PRNewswire/ -- Patient prepping products (PPP) are essential to ensure patient safety. Advantages include cost and time savings and improved efficiency in the allocation of healthcare funds.

New analysis from Frost & Sullivan ( http://www.healthcare.frost.com), Western European Patient Prepping Products Market, finds that the market earned revenues of $866.9 million in 2011 and estimates this to reach $1,302.3 million by 2018. The research covers 2 major segments: IV (custom procedure trays and antiseptic prep pads) and surgical (hair removal, antiseptics, incise drapes, and others including oral and nasal prep products).

"An ageing population has had a positive impact on procedure volumes, boosting the uptake of PPP," notes Frost & Sullivan Industry Analyst Beulah Devadason. "Rising awareness about the need to prevent healthcare associated infections (HAI) is also promoting the uptake of PPP."

However, current economic conditions have resulted in hospitals facing increasingly severe budgeting pressures. This, in turn, has affected manufacturers who have resorted to underselling the competition to win tenders.

Nevertheless, such pricing pressures are expected to have a limited impact on market growth. Instead of price, the focus will be on product efficacy since effective products can help avoid the long term costs associated with infection related hospitalization.

This focus on product efficacy, reliability and quality is highlighting the need for a complete solutions provider.

"Market participants recognize the competitive advantage of providing end-to-end solutions," remarks Devadason. "Most Tier I participants have a comprehensive product line or have entered into strategic alliances to expand their existing product portfolio."

The introduction of ChlorhexidineGluconate (CHG) wipes, and iodine diffusing incise drapes represent efforts at product differentiation. They have the potential to shift market dynamics in a slow growth market and are a strategic response from manufacturers to gain market share.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,192.46 -21.96 -0.12%
S&P 500 2,112.10 +1.36 0.06%
NASDAQ 4,982.0080 -5.8820 -0.12%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs